ESTRELLA IMMUNOPHARMA, INC. Current Assets
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Current Assets of $1.82 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $1.82M.
- 2026-03-31: Assets, Current $2.16M.
- 2025-12-31: Assets, Current $1.68M.
- 2025-09-30: Assets, Current $2.02M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.82M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.16M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $1.68M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.48M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $944.27K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.64M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $2.24M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.45M 10-KT · filed 2025-03-25 | |
| 2024-03-31 | $8.63M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $9.45M 10-Q · filed 2024-02-14 | |
| 2023-06-30 | $2.75M 10-K · filed 2024-09-27 | $129.36K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $81.89K 10-Q · filed 2023-05-18 | |
| 2022-12-31 | $52.43K 10-Q · filed 2023-08-01 | |
| 2022-09-30 | $160.75K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $128.82K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $428.14K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $616.03K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $780.13K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |